Trial Details

COMPLETED
Basic Information
Clinical ID c1623
Identifier NCT04779307
Trial Title A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Colitis, Ulcerative
Interventions DRUG: Vedolizumab
Participant Information
Sponsor Takeda
City Phoenix
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2021-10-19
Primary Completion Date 2025-07-01
Completion Date 2025-07-01